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Abstract. A  variety of cysteine-containing, lipid- 
modified peptides are found to be S-acylated by cul- 
tured mammalian cells. The acylation reaction is 
highly specific for cysteinyl over serinyl residues and 
for lipid-modified peptides over hydrophilic peptides. 
The S-acylation process appears by various criteria to 
be enzymatic and resembles the S-acylation of plasma 
membrane-associated proteins in various character- 
istics, including inhibition by tunicamycin. The sub- 
strate range of the S-acylation reaction encompasses, 
but is not limited to, lipopeptides incorporating the mo- 
tifs myristoylGC- and -CXC(farnesyl)-OCH3, which 
are reversibly S-acylated in various intracellular pro- 
teins. Mass-spectrometric analysis indicates that palmi- 
toyl residues constitute the predominant but not the 
only type of S-acyl group coupled to a lipopeptide car- 
rying the myristoylGC- motif, with smaller amounts of 
S-stearoyl and S-oleoyl substituents also detectable. 
Fluorescence microscopy using NBD-labeled cysteinyl 
lipopeptides reveals that the products of lipopeptide 
S-acylation, which cannot diffuse between membranes, 
are in almost all cases localized preferentially to the 
plasma membrane. This preferential localization is 
found even at reduced temperatures where vesicular 
transport from the Golgi complex to the plasma mem- 
brane is suppressed, strongly suggesting that the plasma 
membrane itself is the preferred site of S-acylation of 
these species. Uniquely among the lipopeptides stud- 
ied, species incorporating an unphysiological N-myris- 
toylcysteinyl- motif also show substantial formation of 
S-acylated products in a second, intracellular compart- 
ment identified as the Golgi complex by its labeling 
with a fluorescent ceramide. Our results suggest that 
distinct S-acyltransferases exist in the Golgi complex 
and plasma membrane compartments and that S-acyla- 
tion of motifs such as myristoylGC- occurs specifically 
at the plasma membrane, affording efficient targeting 
of cellular proteins bearing such motifs to this mem- 
brane compartment. 
VARIETY of integral membrane proteins and revers- 
ibly membrane-associated proteins in  eukaryotic 
cells exhibits posttranslational acylation on one or 
more cysteine residues, a modification that for a number 
of such proteins appears to be dynamic (6, 39, 42, 45, 81, 
82, 84) and, in some cases, is modulated by physiological 
or pharmacological stimuli (15, 31, 45, 46, 63, 86). Integral 
membrane proteins may be S-acylated either on cysteine 
residues near the cytoplasmic termini  of transmembrane 
helixes (3, 14, 28, 30, 32, 68, 74) or on cytoplasmic cysteine 
residues more distant from a transmembrane helix (9, 18, 
21, 88). Among the reversibly membrane-associated pro- 
teins that undergo S-acylation are found a number of src- 
homologous nonreceptor tyrosine kinases, heterotrimeric 
G protein a  subunits and monomeric G proteins (for re- 
views see  10,  43,  44,  61,  65,  75).  S-acylation  has  been 
shown to enhance the membrane association of a variety 
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of proteins of the latter type and thereby to contribute to 
their physiological function (2, 11, 22, 25, 41, 51, 81, 83, 84, 
86, 87, 90, 91). 
To  date,  relatively  little  is  known  about  the  mecha- 
nism(s)  and  the  subcellular  loci  of protein  S-acylation. 
Based on the evidence of kinetic and cellular-fractionation 
studies, S-acylation of some viral and cellular integral mem- 
brane proteins has been suggested to occur in the Golgi 
complex, the endoplasmic reticulum, and/or an intermedi- 
ate  compartment  between these  two structures  (for re- 
views see 68, 69).  However, a variety of S-acylated pro- 
teins appears to be associated with the plasma membrane 
(9, 11, 16, 18, 22, 25, 35, 41, 46, 62, 77, 78, 86, 89), and the 
dynamic nature of this modification suggests that S-acylation 
may also occur either  in  the plasma membrane  or in a 
membrane compartment that rapidly communicates with 
this membrane.  Apparently enzymic activities mediating 
S-acylation of protein substrates have been identified in 
several intact or solubilized membrane preparations (1, 4, 
19, 24, 70, 72) but to date have not been characterized at a 
molecular level.  Certain  integral  membrane  proteins  (7, 
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been shown to exhibit spontaneous S-acylation in vitro in 
the presence of long chain acyl-CoAs, although it remains 
to be determined whether such autocatalytic reactions can 
mediate the S-acylation of proteins in intact cells. 
A variety of eukaryotic intracellular proteins bearing cys- 
teine residues near  terminal  N-myristoylglycyl- or S-pre- 
nylcysteinyl- residues  are  S-acylated  in  vivo (for review 
see 10,  43, 61,  65, 75), even when such motifs are intro- 
duced artificially into chimeric or mutated proteins (2, 4, 26, 
77, 78). These findings suggested that simple lipopeptides 
containing  such  minimal  motifs  might  serve  as  cell-per- 
meant substrates to examine S-acylation in situ in eukary- 
otic cells. We here demonstrate that such lipopeptides, with 
structures  resembling  those  of the lipidated  terminal  se- 
quences of various intracellular proteins, are efficiently and 
specifically acylated on cysteine residues by cultured mam- 
malian cells, by a process whose properties resemble in a 
variety of aspects those observed for the S-acylation of cel- 
lular proteins. Fluorescence microscopy reveals that most 
of these lipopeptides undergo S-acylation preferentially at 
the plasma membrane.  However, a  small  subset of lipo- 
peptides containing an unphysiological acylation motif also 
appears to undergo significant S-acylation in a second spe- 
cific locus, the  Golgi apparatus.  Our results suggest that 
the substrate specificity of the plasma membrane  S-acyl- 
transferase(s) detected here may be rather broad, and that 
the plasma membrane and Golgi S-acylating activities are 
mediated by distinct S-acyltransferases. 
Materials and Methods 
Materials 
[3H]Palmitic  acid (sp ac 40-80 Ci/mmol) was obtained from DuPont Can- 
ada (Mississauga, Ontario). Protected amino acids and other reagents for 
peptide synthesis were obtained from Novabiochem USA (La Jolla, CA) 
or Sigma Chemical Co. (St. Louis, MO).  Cell culture media were pur- 
chased from GIBCO  BRL (Burlington, Ontario). Tunicamycin  (mixed 
isomers) was obtained from Sigma Chemical Co. and stored as a stock so- 
lution in serum-free medium at -80°C. BSA (fraction V, Sigma Chemical 
Co.) was fatty acid depleted by the procedure of Chen (12).  Streptavidin 
(Sigma Chemical Co.) was labeled with Texas red (Molecular Probes, Eu- 
gene, OR) according to the manufacturer's instructions. 
The mono-NBD- derivative of ethylenediamine was prepared by over- 
night reaction of NBD-chloride (100 raM) with five molar equivalents of 
ethylenediamine dihydrochloride and 1.05 equivalents of triethylamine in 
3:1  (vol/vol) chloroform/methanol at  room  temperature.  The  reaction 
mixture was throroughly dried and chromatographed on a column of SP- 
Sephadex C-25 packed in water, eluting with a gradient of 0-30 mM aque- 
ous  NaC1  to  obtain  pure  mono-NBD-ethylenediamine hydrochloride, 
which was recovered by lyophilization. Fluorescent acylpeptides bearing 
the -edNBD group at the carboxyl terminus were then synthesized as de- 
scribed previously for analogous bimanylcysteamine-labeled acylpeptides 
(57, 80). Acylpentapeptides synthesized using standard Fmoc-based, solid- 
phase methods (20)  were purified by flash chromatography, coupled to 
NBD-ethylenediamine using dicyclohexylcarbodiimide/hydroxybenzotri- 
azole in dimethylformamide, then purified by preparative TLC on silica 
gel 60  as described previously (57,  80)  both before and  after  O-  and 
S-deprotection as appropriate. Purity of the final lipopeptide products was 
assessed by thin layer chromatography on both conventional and reverse- 
phase thin layer plates, visualizing both by fluorescence and by charring 
with sulfuric acid spray. 
Methods 
Cell Lines and Cell Culture.  CV-1 and NIH-3T3 cells (obtained from Dis. 
Nahum Sonenberg and Philippe Gros, McGill University) and A431  cells 
(obtained from Dr. Maureen O'Connor-McCourt, NRC Biotechnology 
Research Institute, Montreal, Qurbec) were grown to 85-100%  conflu- 
ency in plastic culture dishes in DME supplemented with 5% FBS, genta- 
mycin (50 I~g/ml), and glutamine (10 raM). 3T3-L1 cells (obtained from 
Dr.  Ralph Germinario, Lady Davis Institute, Jewish General Hospital, 
Montreal, Canada) were grown to 60-80% confluency in the same me- 
dium  supplemented with  10%  serum.  Monolayers were washed three 
times with serum-free medium plus 5 mM pyruvate (SFM)  1 containing de- 
lipidated BSA (3 mg/ml), then three times with SFM alone before incuba- 
tion with lipopeptides and/or [~H]palmitate as described below. 
For cell incubations lipopeptides (as 10 mM stock solutions in dimeth- 
ylformamide) were diluted to 0.5 mM in SFM containing DTI" (5 mM) 
plus either delipidated BSA (68  mg/ml) or, where indicated, sonicated 
POPC (1-palmitoyl-2-oleoyl phosphatidylcholine) vesicles (3  mM) as a 
carrier. After incubation for 20 min at room temperature under argon, the 
mixtures were further diluted to the desired final lipopeptide concentra- 
tions (50 p.M where not otherwise indicated) in SFM and immediately 
added  to  freshly  washed  cell  monolayers.  For  incubations  including 
[3H]palmitate the labeled fatty acid was added to the final incubation mix- 
ture along with an additional 3 mg/ml delipidated BSA. 
Fluorescence Assay of  Lipo~ptide S-Acylation.  Washed cell monolayers 
in 100-ram culture dishes were incubated at 37°C with fluorescent lipopep- 
tide (20 jxM) in POPC vesicles (120  p~M) in SFM. After incubation the 
cells were washed four times with SFM, then incubated for 15 rain in 150 
mM NaC1, 20 mM Tris, 1 mM EDTA, pH 7.4, and harvested by trituration 
with a pasteur pipette (comparable results were obtained by scraping the 
cells from the plates without a 15-min preincubation). The cell suspension 
was pelleted (1,000 g, 5 min at 22°C), resuspended in 0.5 ml of the above 
buffer, chilled to 0°C, and partitioned in 4 ml (final vol) of 2:1:1 (vol/vol/ 
vol) CH2C12/methanol/buffer acidified to pH ca 2 with dilute HCI. The 
lower phase and a second extract of the upper phase were pooled, washed 
once with 1:1 methanol/0.15 M  NaCI, and dried under nitrogen before 
analysis by TLC (Whatman silica gel 60A plates, developing with 0.2% 
acetic  acid,  5-12%  methanol  [depending  on  lipopeptide  polarity]  in 
CH2CIz)  alongside appropriate synthetic standards. After development 
fluorescent bands were moistened, scraped into methanol (3.5 ml), bath 
sonicated to ensure complete elution of the lipopeptide, and quantitated 
by fluorescence (absorption/emission wavelengths 390/472  nm, using a 
spectrofluorimeter [LS-5; Perkin-Elmer Corp., Norwalk, CT]) after pellet- 
ing the silica in a clinical centrifuge. In some experiments a portion of the 
total lipid/llpopeptide extract was taken  for phospholipid assay as de- 
scribed previously (38). 
S-Acylated lipopeptide samples for mass-spectrometric analysis were 
prepared from cells incubated with myrGCG-edNBD (20 raM, 37°C, 3 h) 
as described above, but the S-acylated lipopeptides were twice chromato- 
graphed on glass TLC plates to ensure a  negligible background signal 
from organic contaminants. Fast atom bombardment mass spectrometry 
of these samples was carried out on a ZAB 2F HS instrument, using ni- 
trobenzyl alcohol as the solvent and an instrumental resolution of 1/2,000. 
Appropriate mixtures of synthetic myrGC(acyl)G-edNBD standards in 
known proportions were chromatographed and analyzed in exactly the 
same manner to calibrate the relative sensitivity of mass-spectrometric de- 
tection for different S-acylated species. 
[3H]Paimitate Labeling of Cellular Components.  Cell  monolayers incu- 
bated at 37°C in 12-well culture dishes with [3H]palmitate (with or without 
lipopeptide) were rapidly washed three times at room temperature with 
SFM plus 3 mg/ml delipidated BSA, then five times with 150 mM NaCI, 20 
mM Hepes, pH 7.0. For assay of lipid and lipopeptide labeling the cells 
were then suspended by scraping in 0.4 ml of lifting buffer (250 mM su- 
crose, 20 mM sodium phosphate, 5 mM iodoacetamide, 1 mM EDTA, 1 mM 
phenylmethanesulfonyl fluoride, 10 p~g/ml each leupeptin, aprotinin and 
soybean trypsin inhibitor, pH 7.4). The suspension was extracted at 0°C in 
CH~C1Jmethanol/acidified buffer as above. The washed extract was dried 
under nitrogen and analyzed by two-dimensional TLC on 10 ×  10 cm PE 
SiI-G plates (Whatman), first adding to the extract either the authentic 
palmitoylated lipopeptide or 1-palmitoyl-2-pyrenedecanoyl  PC (which co- 
migrated with cellular PC) as a visual marker of the component(s) to be 
assayed for tritium incorporation. For assay of lipopeptide acylation the 
1. Abbrevations used in this paper: POPC, 1-palmitoyl-2-oleoyl phosphati- 
dylcholine; SFM, serum-free DME supplemented with 5  mM pyruvate 
and 10 mM glutamine. Lipopeptides are designated using the one letter 
code plus these additional abbreviations: -edNBD, (2-((7-nitrobenz-2-oxa- 
1,3-diazol-4-yl)amino)ethyl)amino-;-caBim,  (S-bimanylmercapto)  ethyl- 
amine-; -(faln)-, S-farnesyl-; myr-, N-myristoyl-; -(palm)-, S-palmitoyl. 
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10% methanol (depending on the lipopeptide polarity) in CHIC12 and in 
the second dimension with 0.2 % acetic acid in ethyl acetate (or in 50:50 di- 
ethyl ether/ethyl acetate for the least polar lipopeptides). For assay of 
phosphatidylcholine labeling the plates were developed in the first dimen- 
sion with 50:20:10:10:2  (volume proportions) CH2Cl2/acetonelmethanol/ 
acetic acid/water and in the second with 65:25:1.5:1.5  CH2Cl2/methanol/ 
cone. NH4OI-I/water.  In each case after developing and drying the plates 
the band localized by the fluorescent standard was moistened, recovered 
by scraping and incubated for 24 h in 10 ml of scintillation fluid (Cytoscint, 
ICN Canada, St. Laurent, Qutbec) before counting. In most cases the de- 
veloped plates were also sprayed with En3Hance (Dupont Canada) and 
visualized by autoradiography before scraping individual spots as above. 
For assay of protein acylation, cells incubated with [3H]palmitate were 
scraped into 250 p~l of lifting buffer containing 0.5% Triton X-100, then 
mixed with 25 vol of 2:1 CH2Cl2/methanol and incubated for 40 rain at 
0°C. After centrifugation for 5 rain in a clinical centrifuge the delipidated 
protein pellet (containing >95%  of the input protein) was recovered, 
rinsed twice with 3 ml of cold 2:1 CH2Cl2/methanol, and freed of residual 
solvent under a gentle stream of nitrogen, then dissolved in 80 p,! of 2.5% 
SDS at 60°C. Two 15-1xl samples were withdrawn for protein assay (DC 
protein assay kit; BioRad Laboratories, Mississauga, Ontario, Canada), 
and the remaining 50  p,1 was combined with 12.5  Ixl of 100 mM DTI', 
0.3125 M Tris, 12.5%  glycerol, 0.05% bromophenol blue, pH 6.8, warmed 
to 60°C for 10 min, and analyzed by SDS-PAGE (34). Protein samples for 
autoradiography were analyzed using 10% polyacrylamide gels, which af- 
ter electrophoresis were fixed for 30 rain in 50% aqueous methanol/10% 
acetic acid, then soaked for 15 min in Amplify (Amersham Canada, Oak- 
ville, Ontario)  before drying and autoradiography. Samples to be ana- 
lyzed by scintillation counting were resolved using 12% gels; after electro- 
phoresis the wet gels were cut into slices covering the range of molecular 
masses >10 kD for each lane. The slices were digested overnight in 1 ml of 
1 M hydroxylamine, pH 7.0, then mixed with 15 ml of scintillation fluid 
and incubated for 24 h before counting. 
Fluorescence Microscopy. CV-1 cells grown on glass coverslips to 80- 
90% confluency were washed with SFM for 37°C incubations. 4 and 15°C 
incubations were also carded out as described below, but using HBSS in 
place of SFM in all steps. The washed coverslips were incubated for the in- 
dicated times in 200 p,l of SFM containing 50-100 IxM lipopeptide, 0.5-1 
mM sonicated POPC vesicles, and 0.5 mM DTT. The coverslips were then 
successively washed three times each with ice-cold SFM, 0.4  mM fatty 
acid--depleted albumin in SFM (incubating for 5 min each time) and SFM. 
Ceils were then visualized using an inverted epifluorescence microscope 
(EM35; Carl Zeiss, Inc., Thornwood, NY) equipped with an MC100 camera. 
For colocalization of biotinylated cell surface molecules and cell-associ- 
ated myrGCG-edNBD, washed CV-1 cell monolayers on coverslips were 
first incubated with sulfosuc,  c,  inimidyl-biotin (2 mg/ml) in PBS for 1 h at 
4°C, then washed twice at 4°C with PBS, once with 50 mM glycine in PBS 
and twice with HBSS. The cells were then incubated with Texas red- 
labeled streptavidin (10 Ixg/ml) and myrGCG-edNBD (10 IxM) for 3 h at 
15°C, then SFM and albumin/SFM washed in the cold and examined using 
a confocal microscope (LSM 420; Carl Zeiss, Inc.). Digitized images were 
stored and printed without further modifications using a  digital printer 
(XLS 8300; Eastman Kodak Co., Rochester, NY). 
Results 
Preliminary Characterization of 
Lipopeptide S-Acylation 
In Fig. 1 are shown representative structures for some of 
the  cysteinyl-containing lipopeptides  used  in this  study. 
All of the fluorescent lipopeptides examined partitioned 
efficiently into lipid bilayers at submillimolar lipid concen- 
trations and were shown to transfer rapidly (tin <  I min at 
37°C)  between and across bilayer membranes in fluores- 
cence experiments using unilamellar lipid vesicles as model 
membranes  as  described  previously  (80).  By  virtue  of 
these properties, when added to cultured mammalian cells 
(with serum albumin or lipid vesicles as a carrier), the li- 
popeptides rapidly gain access to intracellular as well as 
surface membranes, as could be demonstrated directly by 
fluorescence microscopy of cells incubated with nonme- 
tabolized  serinyl-lipopeptides  such  as  myrGSG-edNBD 
(see below). 
CV-1 cell monolayers incubated in serum-free medium 
with a fluorescent cysteinyl-containing lipopeptide such as 
myrGCG-edNBD (see Fig. 1) gradually accumulated the 
S-acylated form of the peptide. This process could be moni- 
tored using two complementary assays. In initial experi- 
ments, cells were incubated with the fluorescent lipopeptide 
alone. An organic solvent extract, containing the cell-asso- 
ciated lipopeptide and its derivatives as well as cellular lip- 
ids, was then prepared from the washed cells and analyzed 
by one-dimensional TLC as  described  in  Materials  and 
Methods. The resulting chromatograms revealed the pres- 
ence  of the unmodified lipopeptide, the  S-acylated form 
(identified by its comigration with an authentic S-palmi- 
toylated standard  2 and by its cleavage to the original cys- 
teinyl-lipopeptide with neutral hydroxylamine) and a mi- 
nor spot corresponding to the disulfide-linked lipopeptide 
dimer; no other fluorescent products were detected under 
these conditions. In a representative experiment, during a 
2-h incubation at 37°C with 20 IxM myrGCG-edNBD the 
cells accumulated 0.75 nmol of S-acylated lipopeptide, 0.10 
nmol of unmodified lipopeptide, and 0.05 nmol of disul- 
fide-oxidized lipopeptide dimer per mg of cellular protein 
(2.9, 0.4, and 0.2 nmol, respectively, per p,  mol total cellular 
phospholipid). Cells incubated with the alternative fluo- 
rescent-labeled lipopeptide myrGCG-caBim (Fig. 1) under 
otherwise identical conditions accumulated a similar amount 
of S-acylated lipopeptide (1.04 nmol/mg cellular protein), 
indicating that the  S-acylation is not dependent on the 
presence of the NBD group. The lipopeptide myrGSG-ed- 
NBD was also taken up by the cells, but in this case no de- 
tectable  fluorescent material  other  than  the  original li- 
popeptide was recovered. 
Incubations  of cells  with  lipopeptides  were  normally 
carried out in the presence of a low concentration of DTT 
(0.5 mM), which was required to minimize the oxidation of 
cysteinyl-lipopeptides during extended incubations. How- 
ever, in control experiments we found that DTI" was not 
required for efficient lipopeptide S-acylation during short 
incubations (0-30 rain), where lipopeptide oxidation was 
limited, and did not significantly affect either cellular mor- 
phology or the S-acylation of cellular proteins under the 
conditions used here. 
In subsequent experiments, to increase the sensitivity of 
the lipopeptide S-acylation assay and the number of sam- 
ples that could be simultaneously examined, we modified 
the above assay by coincubating ceils with lipopeptide and 
tritiated palmitic acid. An organic solvent extract was then 
prepared  as above, mixed with the appropriate S-palmi- 
toylated lipopeptide standard and separated by two-dimen- 
sional TLC as described in Materials and Methods. For all 
monocysteinyl-lipopeptides tested autoradiography of the 
2. The S-acylated lipopeptides recovered from CV-1 cells comigrated with 
chemically prepared standards bearing long chain S-acyl groups (palmi- 
toyl, stearoyl, or oleoyl, which were not resolved in our chromatographic 
systems) but showed significantly higher mobilities than standards bearing 
shorter S-acyl groups such as acetyl. This result, which was observed for 
all lipopeptide substrates examined, is consistent with our direct mass- 
spectrometric  demonstration  (described  later  in  this  section)  that 
myrGCG-edNBD is modified with palmitoyl, stearoyl, and oleoyl chains. 
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Figure 1.  Structures of the fluorescent  lipopeptides  used in this 
study. 
resulting TLC chromatogram revealed a unique novel ra- 
diolabeled band, comigrating exactly with the S-palmitoy- 
lated lipopeptide standard, as illustrated in Fig. 2 A for CV-1 
cells  incubated  with  myrGCG-edNBD.  Under  the  TLC 
conditions used the S-acylated lipopeptide was in all cases 
cleanly resolved from other radiolabeled  bands  present, 
allowing reliable quantitation of the formation of S-[3H]acyl 
lipopeptide.  Under  the  same  conditions  cells  incubated 
with the serinyl-lipopeptide myrGSG-edNBD showed neg- 
ligible incorporation of radioactivity into material migrat- 
ing at the position of myrGS(palm)G-edNBD (Fig. 2 B). 
The lipopeptide acylation process observed here thus ap- 
pears  to  be highly selective for modification of cysteine 
over serine residues. 
In  additional  experiments  we  examined  further  basic 
characteristics of the lipopeptide S-acylation reaction de- 
scribed above, using CV-1 cells with myrGCG-edNBD as 
the lipopeptide substrate. As illustrated in Fig. 3 A, forma- 
tion of radiolabeled S-acylated lipopeptide proceeds over 
a time course of at least several hours, with no detectable 
initial lag even when the lipopeptide and [3H]palmitate are 
added  to the cells simultaneously. This latter result sug- 
gests that the pool(s) of acyl-donor molecules for the li- 
popeptide S-acylation reaction rapidly becomes labeled 
to  essentially constant specific activity upon  addition  of 
exogenous [3H]palmitate. In agreement with this conclu- 
sion, the extent of formation of radiolabeled myrGC(acyl) 
G-edNBD  during a  1-h coincubation of CV-1  cells with 
[3H]palmitate plus myrGCG-edNBD was  not detectably 
enhanced by preincubating the cells with the labeled palm- 
itate for up to 2 h before lipopeptide addition (not shown). 
Pulse-chase experiments, in which cells were continuously 
incubated with myrGCG-edNBD (50 ixCi), first with [3H]pal- 
mitate (50 IxCi/ml, 1 h) and then, after repeated washings, 
with  unlabeled  palmitate  (500  IxM),  demonstrated  turn- 
over of the labeled S-acylated lipopeptide with a half-time 
of roughly 4 h  (not shown). As shown in Fig. 3 B, when 
CV-1 cell monolayers are incubated for 2 h with [3H]palmi- 
tate (50 ~Ci/ml) and varying concentrations of myrGCG- 
edNBD, formation of radiolabeled S-acylated lipopeptide 
increases in a apparently saturable manner as a function of 
the added lipopeptide concentration. Based on the above 
results further experiments were carried out using a stan- 
dard lipopeptide concentration of 50 I~M and an incuba- 
tion time of 2 h  except where otherwise indicated. These 
conditions  allowed  accurate  quantitation  of  S-acylation 
even for lipopeptides that were modified much less effi- 
ciently than myrGCG-edNBD. 
Figure 2.  Autoradiogram of 
TLC chromatograms of lipid/ 
lipopeptide  samples  from 
CV-1 cells incubated  for 2 h 
at  37°C with  [3H]palmitate 
(50 txCi/ml) plus  either (A) 
50 I~M myrGCG-edNBD or 
(B) 50 IxM myrGSG-edNBD. 
Samples  were applied  as  a 
1-cm band  at  the  origin  to 
optimize  resolution  in  the 
first  dimension.  The  band 
marked with an arrowhead in 
A  comigrated  exactly  with 
authentic  myrGC(palm)G- 
edNBD added to the sample 
before chromatography.  The 
minor  bands  migrating 
around the diagonal at Re = 
ca 0.2 in chromatogram  (B) 
were also detected in chromatogam (A) upon longer exposures. No labeled band was observed in chromatogram (B) at the position of 
either myrGS(acyl)G-edNBD  (arrowhead) or myrGC(acyl)G-edNBD,  even after longer exposures. Other experimental details were as 
described in Materials and Methods. 
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Figure 3.  (A) Time course of 
incorporation of [3H]palmitate 
into  myrGC(acyl)G-edNBD 
by CV-1 cells incubated with 
myrGCG-edNBD  (50  IxM) 
and  [3H]palmitate  (50  ~Ci/ 
ml) at 37°C. (B) Lipopeptide 
concentration  dependence  of 
the  incorporation of [3H]pal- 
mitate  into  myrGC(acyl)G- 
edNBD by CV-1 cells during 
a 2-h incubation  at 37°C. In 
both  panels,  values  shown 
represent the mean (-_+ SD) 
of  three  determinations  at 
each time  point using sepa- 
rately incubated cell samples. 
Time courses determined in 
replicate  experiments  were 
very similar in form to that 
shown but varied  somewhat 
in  the  absolute  magnitude 
of  lipopeptide-incorporated 
counts at any given time/con- 
centration. Other experimen- 
tal details were as described 
in Materials and Methods. 
S-Acylation by CV-1 cells of exogenous myrGCG-edNBD 
and several other lipopeptides tested was readily detected, 
using the fluorescence-based assay described above, when 
the incubation temperature was reduced from 37 to 15°C 
or even to 4°C, although the rate of S-acylation was signifi- 
cantly  reduced  at  the  latter  temperatures  (not  shown). 
However, by suitably prolonging the time of incubation of 
cells with lipopeptides at these lower temperatures, the 
S-acylated form of the lipopeptides could be accumulated 
to levels comparable to those observed at 37°C. 
The  nature  of  the  S-acyl  groups  incorporated  into 
myrGC(acyl)G-edNBD by CV-1 cells was examined by mass 
spectrometry. Cells were incubated for 3  h  with  20  I~M 
myrGCG-edNBD (without tritiated palmitate), and the 
S-acylated lipopeptide was extracted and purified by TLC 
as  above.  Fast  atom  bombardment  mass-spectrometric 
analysis of the isolated material, combined with parallel 
analyses  of  appropriate  synthetic  S-acylated  standards, 
identified peaks with masses corresponding to the S-pal- 
mitoyl (77%), S-stearoyl (15%), and S-oleoyl (8%) forms, 
in the relative molar proportions indicated. No other type 
of S-acyl substituent could be identified above the detec- 
tion threshold  (estimated as 2-3 mol%  of total lipopep- 
tide-coupled S-acyl chains). 
To determine whether the S-acylation of cysteinyl-lipo- 
peptides  might  be  peculiar  to  CV-1  cells,  using  the 
[3H]palmitate-labeling assay we compared the S-acylation 
of myrGCG-edNBD by four cell lines: CV-1 (monkey kid- 
ney fibroblast) cells, the murine fibroblast line NIH-3T3, 
the human epidermoid carcinoma cell line A431, and the 
preadipocytic murine cell line 3T3-L1. As shown in Table 
I, all of these cell lines showed substantial S-acylating ac- 
tivity toward  myrGCG-edNBD but  virtually no  activity 
(>103-fold less) toward the analogous serinyl lipopeptide. 
While the values shown in Table I cannot be assumed to 
reflect quantitatively the relative S-acylating activities of 
the different cell lines (given the possibility of differences 
in  the  specific  activities  of the  relevant  [3H]acyl-donor 
pool[s] between cell lines), it is clear that these cell types 
are at least qualitatively similar in their abilities to acylate 
selectively the cysteinyl, but not the serinyl lipopeptide. 
Comparison of S-Acylation  of  Exogenous Lipopeptides 
and Cellular Proteins 
We have previously shown (57) that in model systems cys- 
teinyl-containing lipopeptides  like  those  examined  here 
can acquire S-acyl groups by nonenzymatic trans-S-acyla- 
tion  reactions from other long-chain  acyl thioesters, in- 
cluding S-acylpeptides, when both species are present in 
the same lipid bilayer. It is thus conceivable in principle 
that lipopeptides such as myrGCG-edNBD could acquire 
S-acyl groups by nonenzymatic exchange from S-acylated 
membrane  proteins.  To determine whether this  mecha- 
Table L Incorporation of [3H]Palmitate into myrGC(acyl)G- 
edNBD versus myrGS(acyl)G-edNBD by Different Mammalian 
Cell Lines 
Incorporation  of [3H]palmitate 
(cpm/l,  zg cellular protein) into: 
Cell line  myrGC(acyl)G-edNBD  myrGS(acyl)G-edNBD 
CV-1  2,262 -+ 60  1.6 ±  0.2 
A431  2,161  ±  124  3.3 ±  0.9 
NIH-3T3  4,777  -+ 838  4.8 ±  2.2 
3T3-L1  6,645 ~  1076  5.1  -+ 2.3 
Cell monolayers were incubated for 2 h at 37°C with myrGCG-edNBD (50 ~M) plus 
[3H]palmitate  (50 /zCi/mi)  and subsequently analyzed for formation of [3HI-labeled 
S-acylated lipopeptide as described in Materials and Methods.  Values shown are 
means (-+ SD) of determinations for triplicate  cell samples incubated in parallel in one 
experiment; a duplicate experiment gave a similar pattern of results but ~25% higher 
labeling of the lipopeptides. 
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of exogenous cysteinyl lipopeptides, we compared the ex- 
tent  and  kinetics  of S-[3H]acylation of the  endogenous 
proteins of CV-1 cells versus added myrGCG-edNBD. 
CV-1 cells readily incorporated radiolabel from exoge- 
nous [3H]palmitate into cellular proteins, as demonstrated 
by SDS-PAGE and autoradiography of total cellular pro- 
teins (Fig. 4, lane 3). The right-most lane of Fig. 4 repre- 
sents  a  parallel sample  (containing an equal amount of 
protein applied to the gel) that was treated with neutral 
hydroxylamine (16 h, 22°C) before electrophoresis. The al- 
most complete disappearance of all major labeled bands 
upon hydroxylamine treatment (89-92%  of total protein- 
associated counts, determined by scintillation counting of 
three independent samples) suggests that at most a small 
fraction of the  incorporated  label  represents  (hydroxy- 
lamine-resistant)  amide-linked  N-[3H]myristoyl  groups, 
which in principle could arise via catabolism of [3H]pal- 
mitic acid. 
To quantitate [3H]palmitate labeling of cellular proteins, 
solvent-delipidated proteins were separated from residual 
lipids  and other low molecular weight contaminants by 
SDS-PAGE, and protein-linked 3H-acyl groups were quan- 
titated by liquid scintillation counting as described in Ma- 
terials and Methods. In Fig. 5 we compare the measured 
extents of radiolabel incorporation into cellular proteins, 
S-acylated lipopeptide, and phosphatidylcholine, a major 
cellular phospholipid, when CV-1 cells were incubated for 
2 h  at 37°C with [3H]palmitate (200  ~Ci/ml) and 50 IxM 
myrGCG-edNBD. As shown in this figure, during such in- 
cubations the incorporation of radiolabel into the S-acy- 
lated  lipopeptide  exceeds  that  into  cellular proteins  by 
over tenfold and in fact is almost 20% as large as the incor- 
poration of radiolabel into phosphatidylcholine. While the 
presence of the lipopeptide significantly reduces protein 
3H-acyl labeling in such experiments (Fig. 6 A, solid cir- 
cles), the magnitude of this effect is only approximately 
twofold  at  the  50  ~M  lipopeptide  concentration  used 
above.  Pulse-chase experiments,  in which cells were  la- 
beled for 1 h with 200 ~Ci/ml [3H]palmitate, washed, and 
Figure 4.  SDS-PAGE analy- 
sis  of total  cellular proteins 
from  CV-1 cells incubated 
with [3H]palmitate (200 ~Ci/ 
ml)  for  2  h  at  37°C. Left 
lanes,  Coomassie  staining 
profiles of samples incubated 
for 16 h at room temperature 
either with 1 M Tris, pH 7.0 
(-), or 1 M hydroxylamine, 
pH 7.0 (+), containing 0.1% 
SDS. Right lanes, autoradio- 
grams of  replicate  aliquots 
of the same samples. Migra- 
tion positions of protein stan- 
dards of known molecular mass (in kD) are shown at the left. Af- 
ter Tris or hydroxylamine treatment protein samples were twice 
precipitated with cold 2"1 CH2C12/methanol  (giving >90%  final 
recovery of total protein)  before SDS-PAGE analysis. Protein 
assay  of  loaded  samples and  scanning  densitometry  of  the 
stained gels confirmed that equal amounts of protein were loaded 
for Tris- and hydroxylamine-treated  samples. 
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Figure 5.  Comparison of 3H 
incorporation into total cellu- 
lar  protein,  myrGC(acyl)G- 
edNBD (mGC(acyl)G-), and 
phosphatidylcholine (PC) by 
CV-1 cells incubated for 2 h 
with [3H]palmitate (200 p~Ci/ 
ml)  and  myrGCG-edNBD 
(50 IxM) at 37°C. Labeling of 
protein,  lipopeptide,  and 
phosphatidylcholine were de- 
termined as described in Ma- 
terials and Methods. Values 
shown  represent  the  mean 
(+-- SEM) for four indepen- 
dent experiments, each using 
three  separately  incubated 
cell samples. 
then chased with unlabeled palmitate (500  p.M), showed, 
moreover, no significant effect of myrGCG-edNBD (50 ~M) 
on the overall rate of turnover of total protein-bound 3H- 
acyl groups (not shown). These results collectively suggest 
that S-acylated cellular proteins do not constitute a suffi- 
ciently large reservoir of 3H-acyl groups to serve as a major 
donor of such groups for S-acylation of myrGCG-edNBD. 
The conclusion just noted is supported by comparing the 
time courses of 3H-acyl labeling of cellular proteins and 
of exogenous myrGCG-edNBD when CV-1 cells are incu- 
bated with [3H]palmitate  (200 ~Ci/ml). As shown in Fig. 6 B, 
upon addition of labeled palmitate total labeling of cellu- 
lar  proteins  increases  progressively  over  several  hours 
without or  (not shown) with myrGCG-edNBD present. 
Autoradiography  of  3H-acylated  cellular  proteins  (not 
shown) revealed no major protein bands that reached a 
constant level of 3H incorporation in less than 2-4 h after 
addition of [3H]palmitate. As noted above, the incorpora- 
tion of label into myrGC(acyl)G-edNBD upon addition of 
labeled palmitate proceeds at a steady rate, with no detect- 
able initial lag when the lipopeptide and [3H]palmitate are 
added to the cells simultaneously (Fig. 3 B) and with no 
enhancement of the rate  of [3H]palmitate incorporation 
when the labeled fatty acid is added up to 2 h before add- 
ing  the  lipopeptide.  These  findings  appear  inconsistent 
with  a  hypothetical  precursor-product  relationship  be- 
tween S-acylated cellular proteins  and the  S-acylated li- 
popeptide. 
The above results effectively  rule out the possibility that 
exogenous  cysteinyl lipopeptides  such  as  myrGCG-ed- 
NBD acquire S-acyl groups primarily by nonspecific trans- 
acylation reactions from S-acylated cellular proteins. Simi- 
lar  results  were  obtained  in  parallel  experiments  using 
other lipopeptides discussed below (not shown), including 
species that were S-acylated considerably less efficiently 
than myrGCG-edNBD. 
The antibiotic tunicamycin, first characterized as an in- 
hibitor of protein glycosylation, has also been shown to in- 
hibit protein S-acylation in cultured neuronal cells at rela- 
tively high concentrations (53). It was therefore of interest 
to compare the effects of tunicamycin on the S-acylation 
by  CV-1  cells  of cellular proteins  and  of myrGCG-ed- 
NBD. As shown in Fig. 7, tunicamycin inhibited the S-acy- 
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Figure  6.  (A )  Effect  of 
myrGCG-edNBD (filled cir- 
cles)  or  myrGSG-edNBD 
(filled  diamonds)  on 
[3H]palmitate labeling of to- 
tal proteins from CV-1 cells. 
Cells were incubated  for 2 h 
at  37°C with  [3H]palmitate 
(200 ixCi/ml) and  the  indi- 
cated  concentrations  of 
myrGCG-edNBD, then ana- 
lyzed for 3H labeling of total 
cellular  proteins  as  de- 
scribed  in  Materials  and 
Methods. (B) Time course of 
[3H] labeling of total cellular 
proteins  by CV-1 cells incu- 
bated  with  [3H]palmitate 
(200 txCi/ml) at  37°C. Data 
shown  represent  the  mean 
(-  half-range)  determined 
for duplicate cell samples, in- 
cubated  separately  with  la- 
beled palmitate, at each time 
point in a representative ex- 
periment.  Replicate  experi- 
ments gave comparable  pat- 
terns  of  results  but  varied 
somewhat  in  the  absolute 
levels of protein labeling. 
lation of both types of acceptor molecule over a  similar 
range  of concentrations,  albeit  with  moderately greater 
potency for inhibition of lipopeptide S-acylation. The fact 
that the inhibition profiles are not identical may not be 
surprising,  as  protein S-acylation may occur in  multiple 
compartments and will reflect the modification of newly 
synthesized proteins as well as of proteins undergoing S-acyl 
turnover. 
Structural Specificity of Lipopeptide S-Acylation 
In the experiments summarized in Fig. 8, we compared the 
ability of CV-1  cells to S-acylate cysteinyl-containing li- 
popeptides of varying sequence and structure. To this end 
CV-1 cells were coincubated for 2 h at 37°C with tritiated 
palmitate (50 p,  Ci/ml) and different lipopeptides (50 p~M) 
in serum-free medium, and formation of radiolabeled S-acyl- 
peptide was subsequently assayed as described above. In 
control experiments we found that the relative efficiencies 
of S-acylation of several different lipopeptides tested un- 
der the above conditions reflected faithfully the relative 
initial  S-acylation rates measured for these  species over 
shorter time courses (not shown). To ensure that different 
lipopeptides would partition to similar concentrations into 
cellular membranes  (in competition with the lipopeptide 
carrier) in these experiments we used as carrier POPC ves- 
icles, which should bind the lipopeptides in a manner simi- 
lar to the lipid bilayers of membranes. In each experiment 
the extent of S-acylation of a given lipopeptide was nor- 
realized to the cellular protein content and to the level of 
S-acylation of myrGCG-edNBD measured in parallel in- 
cubations, to correct for variations between experiments 
in cell number and/or in the specific activity of the cellular 
pool(s) of the [3H]acyl donor(s) for the lipopeptide S-acy- 
lation reaction. 
As the data shown in Fig. 8 demonstrate, a  variety of 
cysteinyl lipopeptides can be S-acylated by CV-1 cells, al- 
though the rate of acylation varies substantially with the 
structure of the lipopeptide. Taking as a reference the li- 
popeptide myrGCG-edNBD, it can be seen from Fig. 8 A 
that increasing the bulk of the amino acid side chain at po- 
sition 1 consistently decreases the efficiency of acylation, 
most  markedly when  the  side  chain  is  branched  at  the 
beta-carbon.  Nonetheless,  significant  S-acylation  is  ob- 
served even for lipopeptides bearing bulky residues such 
as Ile, Val, or Phe at the myristoylated NH2-terminal posi- 
tion. Substitution of glycine by leucine, valine, or threo- 
nine at the lipopeptide 3 position also decreases somewhat 
the  efficiency of S-acylation.  Interestingly,  the  lipopep- 
tides  myrCG-edNBD  and  myrC-edNBD,  in  which  the 
modifiable cysteinyl residue is itself N-myristoylated, were 
acylated  with  significantly greater  efficiencies than  was 
myrGCG-edNBD (Fig.  8  B).  Evidence discussed  below 
suggests that myrCG- and myrC-edNBD are substrates for 
an additional S-acylating activity that does not efficiently 
modify the other lipopeptides discussed above. The serinyl 
lipopeptides myrSG-edNBD and myrS-edNBD (not shown) 
showed essentially no 3H labeling (>200-fold less than for 
myrCG- or myrC-edNBD) in parallel incubations. 
The S-acylation of several NH2-terminally myristoylated 
pentapeptides  was  examined in  parallel  with  the  above 
studies  of the  modification of myristoylated tripeptides 
(Fig.  8  C).  The lipopeptide myrGCGCS-edNBD, repre- 
senting the NH2-terminal sequence of the human nonre- 
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Figure 7.  Tunicamycin inhibition of 3H incorporation into total 
cellular proteins (open circles) or myrGCG-edNBD (closed circles) 
by CV-1 cells incubated for 2  h  at 37°C with [3H]palmitate  (200 
izCi/ml) and myrGCG-edNBD (50 ixM). For clarity of presenta- 
tion the curves for inhibition of lipopeptide and protein S-acylation 
have been scaled to pass through a common y-intercept; actual 
3H-labeling  of  lipopeptide  (per  Ixg  of  sample  protein)  was 
roughly 15-fold higher than protein labeling at zero tunicamycin. 
Data shown are from a representative experiment using triplicate 
(independently incubated) samples for determination of lipopep- 
tide acylation and single samples for determination of protein acy- 
lation. Other details were as described in Materials and Methods. 
ceptor tyrosine kinase p56  tck, was  recovered from CV-1 
cells in both mono- and diacylated forms (52 _+ 4% and 48 _+ 
4%  of total S-acylated lipopeptide, respectively, in nine 
determinations).  Unfortunately, this  lipopeptide showed 
an unusually fast rate of oxidation in solution even in the 
presence of DTI', so that the measured efficiency of S-acy- 
lation shown for this species in Fig. 8 C is artifactually 
diminished. The efficiency of S-acylation of the lipopenta- 
peptide myrGCGSS-edNBD was similar to that of myrGCG- 
edNBD, while that for myrGSGCS-edNBD was approxi- 
mately twofold lower. The lipopeptide myrGCTLS-edNBD, 
representing the NH2-terminal sequence of the heterotri- 
meric G protein subunit G~i3, was also readily acylated by 
CV-1 cells, albeit with a somewhat lower efficiency than 
were the other lipopentapeptides examined. 
In Fig. 8 D are summarized data describing the effect of 
the hydrophobic 'anchor' group on the S-acylation of a se- 
ries of NBD-labeled lipopeptides containing the core se- 
quence -GCG-. Within  a  homologous series of lipopep- 
tides  (acyl)-GCG-edNBD,  members  with  N-acyl  chain 
lengths from 10 to 16 carbons were S-acylated with effi- 
ciencies that varied over a range of only some twofold. By 
contrast, acetyl-GCG-edNBD was  acylated with  an effi- 
ciency over 100-fold lower than that observed for the cor- 
responding N-myristoyl species. These results suggest that 
the ability of the N-acyl group to promote membrane par- 
titioning may be more important than its specific structure 
in determining the  suitability of these cysteinyl-lipopep- 
tides as acylation substrates. 3 In agreement with this con- 
clusion,  the  'inverted'  lipopeptide  NBD-GCG-ed-myris- 
toyl and the farnesylated peptide NBD-GCGC(farn)-OMe 
(see Fig. 1) were both found to be S-acylated with efficiencies 
similar to those observed for myrGCG-edNBD (Fig. 8 D). 
Fluorescence-Microscopic Localization of 
S-Acylating Activity 
As noted above, in their unmodified forms the fluorescent 
lipopeptides employed in this study transfer rapidly be- 
tween and across bilayer membranes. By contrast, as we 
have recently demonstrated (76), in their S-acylated (dou- 
bly  lipid-modified)  forms  such  lipopeptides  exhibit  ex- 
tremely slow rates of spontaneous interbilayer exchange. 
As a result, fluorescent cysteinyl lipopeptides are expected 
to  accumulate preferentially in  the  membrane compart- 
ment(s) where they become S-acylated, permitting these 
compartments  to  be  visualized  by  fluorescence micros- 
copy. The specificity of fluorescence labeling of such com- 
partments  can  be  enhanced  by  repeatedly washing  the 
cells at 4°C with albumin-containing solutions, which were 
shown to extract the (diffusible) non-S-acylated form of 
the lipopeptides efficiently (>90%) and selectively, and by 
carrying out the acylation reactions at reduced tempera- 
tures (4 or 15°C)  where a  number of processes of inter- 
compartmental vesicular transport of proteins and lipids 
are strongly suppressed (55). 
As shown in Fig.  9 a,  CV-1  cells incubated for 4 h  at 
15°C  with myrGCG-edNBD (50 IxM)  show pronounced 
selective labeling of the plasma membrane. Similar promi- 
nent labeling of the plasma membrane was observed for 
cells incubated with this lipopeptide at 4 or at 37°C  (not 
shown). Strong preferential labeling of this membrane was 
observed as well in cells not washed with albumin before 
microscopic examination, although in this case weak label- 
ing  of intracellular membranes  could also  be  seen  (not 
shown). 
To confirm that  the  structure  prominently labeled  by 
myrGCG-edNBD was in fact the plasma membrane, cells 
were surface biotinylated with sulfosuccinimidyl biotin at 
4°C,  then  incubated  with  lipopeptide  for  4  h  at  15°C, 
washed  repeatedly  with  cold  albumin-containing  SFM, 
and  finally  decorated  at  4°C  with  Texas  red-labeled 
streptavidin. The doubly-labeled cells were then examined 
by  confocal  microscopy  immediately  after  warming  to 
room temperature, giving the results illustrated in Fig. 9, c 
and d. The very close correspondence of the distributions 
of S-acylated  lipopeptide  (Fig.  9  c)  and  surface-bound 
Texas red-streptavidin (Fig. 9 d) confirm that the S-acy- 
lated lipopeptide is generated predominantly if not exclu- 
sively in the plasma membrane under these conditions. A 
3.  It may appear surprising, in the light of the results of Peitzsch and 
McLaughlin (54), that an N-acyl group as short as 10 carbons could still 
support significant membrane binding of an N-acylpeptide like those ex- 
amined here. However, the NBD group itself also appears to contribute 
modestly to the net affinity of these lipopeptides for lipid surfaces, as was 
observed previously for NBD-labeled phospholipids (47; Silvius,  J., un- 
published results). We have found in control experiments carried out as 
described previously (80)  that  even N-decanoyl-GCG-edNBD exhibits 
significant affinity for binding to lipid bilayers at the effective membrane- 
lipid concentrations prevailing within a  typical cell (several mM [23]), 
while the N-acetylated species does not. 
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Figure 8.  Relative efficiencies of S-acylation of lipopeptides of different structure and sequence. CV-1 cells were incubated for 2 h at 
37°C with [3H]palmitate (50 ~Ci/ml) and the indicated lipopeptides, then harvested and analyzed for [3H]palmitate incorporation into 
S-acyl iipopeptide as described in Materials and Methods. For each experiment the extent of 3H incorporation into each (S-acylated) li- 
popeptide was normalized to sample protein content and to the mean level of 3H incorporation into myrGC(acyl)G-edNBD measured 
in parallel incubations. Data shown represent the mean (--- SEM) determined using triplicate samples in each of a minimum of three in- 
dependent experiments. 
small amount of vesicular fluorescence can be observed in- 
tracellularly for both the S-acylated lipopeptide and the la- 
beled  streptavidin  in  Fig.  9,  c  and  d,  reflecting a  small 
amount of internalization of plasma membrane that was 
observed during the limited time (~5 min) that the cells 
were exposed to room temperature during microscopic vi- 
sualization.  As vesicular transport of materials from the 
trans-Golgi to the plasma membrane has been shown to be 
strongly inhibited at temperatures ~<15°C (13, 29, 40, 50, 
67,  79),  the  above results  strongly implicate  the  plasma 
membrane itself as the site of S-acylation of myrGCG-ed- 
NBD. 
As illustrated in Fig. 9 b, the S-acylated derivatives of 
the  lipopeptides  myrGCT-  and  myrACG-edNBD  also 
showed  preferential  accumulation  in  the  plasma  mem- 
brane  under the  above incubation conditions. The lipo- 
peptides  myrGCGCS-,  myrGCGSS-,  myrGSGCS-,  myr 
GCTLS-, myrGCL-, myrQCG-, myrSCG-, myrVCG- and 
myrLCG-edNBD,  decanoyl-LCG-edNBD,  NBD-GCGC 
(farn)-OMe, and the inverted lipopeptide NBD-GCG-ed- 
myristoyl were  also  examined as  above and  all  showed 
preferential localization to the plasma  membrane  under 
these conditions (not shown). 
In contrast to the behavior of the cysteinyl-containing li- 
popeptides just discussed, cells labeled with the lipopep- 
tide myrGSG-edNBD (without subsequent albumin wash- 
ing, which removed the intracellular fluorescence) showed 
widespread staining of a variety of intracellular membrane 
compartments and only weak staining of the plasma mem- 
brane, at either 15°C (Fig. 9 e) or 37°C (not shown). This 
pattern of staining is consistent with that expected given 
that  this  lipopeptide  can  readily  diffuse  between  and 
across  cellular membranes but does not  become O-acy- 
lated  (and hence trapped)  in  any cellular compartment. 
The pattern  of staining  observed with myrGSG-edNBD 
(or  with  myrGSGSS-edNBD  [not  shown])  is  similar  to 
that  observed  for  cells  incubated  with  the  fluorescent 
phospholipid C6-NBD-PA (Fig. 9f), which has been previ- 
ously shown to be rapidly converted to fluorescent dia- 
cylglycerol at the cell surface and subsequently to become 
incorporated into a variety of cellular membranes (49). 
While a variety of cysteinyl-containing lipopeptides were 
preferentially accumulated (as their S-acyl derivatives) in 
the plasma membrane, the lipopeptides myrC-edNBD and 
myrCG-edNBD  gave  strong  labeling  not  only  of  the 
plasma membrane but also of a distinct, perinuclear com- 
partment as illustrated in Fig. 10. This pattern of cell label- 
ing was observed for both lipopeptides at 37°C (illustrated 
in Fig. 10 a for myrC-edNBD) and at 15°C (Fig. 10, c and e). 
MyrC-edNBD also gave a similar pattern of cell labeling 
at 4°C, although myrCG-edNBD gave less distinct perinu- 
clear labeling at this temperature. By contrast, the serinyl- 
lipopeptides myrS-edNBD (Fig. 10 b) and myrSG-edNBD 
(not shown) labeled a variety of cellular membranes, with 
no evident preferential labeling of either the plasma mem- 
brane or the perinuclear compartment just noted either at 
15 or 37°C. This result suggests that the addition of a sec- 
ond acyl chain (which as shown above does not occur for 
the serinyl lipopeptides) is essential for the preferential lo- 
calization of species such as myrC- and myrCG-edNBD to 
the  perinuclear  compartment  as  well  as  to  the  plasma 
membrane. 
To  identify the  perinuclear  compartment  labeled  by 
myrCG-edNBD  and  myrC-edNBD,  cells  were  simulta- 
neously incubated with one of these lipopeptides and with 
Cs-DECA-ceramide  (N-[[[8-[7-diethylamino]coumarin- 
3-yl]carbonyl]amino]octanoylsphingosine),  which like other 
fluorescent ceramides preferentially labels the Golgi appa- 
ratus, particularly at  reduced temperatures  (33,  36,  50). 
The  strong  colocalization of the  two probes  within  the 
perinuclear structures after coincubation at 15°C (Fig. 10, 
c-f), as  well  as  at  37°C  or,  for myrC-edNBD,  4°C  (not 
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croscopic  localization of the 
intraeellular site(s)  of S-acy- 
lation  of  lipopeptides  in 
CV-1 cells, a-d represent cell 
samples incubated  for 4 h at 
15°C  with  lipopeptides  (50 
p~M), then washed with albu- 
min  at  4°C  to  remove  un- 
modified  lipopeptide  as  de- 
tailed  in  Materials  and 
Methods. (a and b) Conven- 
tional microscopic images of 
cells  incubated  with  (a) 
myrGCG-edNBD  or  (b) 
myrGCT-edNBD  (left  half 
panel)  or  myrACG-edNBD 
(right half panel).  (c and d) 
Confocal microscopic images 
of  surface-biotinylated  cells 
incubated with myrGCG-ed- 
NBD, then washed  with  al- 
bumin/SFM,  decorated with 
Texas  red-labeled streptavi- 
din at 4°C and finally visual- 
ized  immediately  after  re- 
warming to room temperature: 
(c) NBD-labeled  lipopeptide 
image; (d) Texas red-strepta- 
vidin image.  (e and f) Con- 
ventional microscopic images 
of cells incubated  for 2 h at 
15°C  with  (e)  myrGSG- 
edNBD (50  p.M) or  00  C6- 
NBD-PA (50 IxM, using soni- 
cated  POPC  vesicles  [350 
p~M] as carder). Bar, 10 ixm. 
shown) confirms that the second compartment labeled by 
myrC(acyl)-edNBD and myrC(acyl)G-edNBD is the Golgi 
apparatus.  Previous studies  (37,  67,  73)  have  suggested 
that vesicular transport of materials from the ER to the 
Golgi  is  effectively suppressed  at  temperatures  <~15°C. 
The  absence  of  discernible  reticular  staining  and  the 
strong Golgi labeling in cells incubated with myrC- and 
myrCG-edNBD at 15°C  (and with myrC-edNBD at 4°C) 
suggests that these lipopeptides accumulate in the Golgi 
through S-acylation in this compartment itself, rather than 
through S-acylation in the endoplasmic reticulum followed 
by bulk membrane transport to the Golgi. This conclusion 
can be compared with previous results which suggest that 
S-acylation of various integral membrane proteins occurs 
posttranslationally in the c/s-Golgi or in  an immediately 
preceding compartment along the secretory pathway (8, 
58, 71). The observation that both lipopeptides also accu- 
mulate  in  the  plasma  membrane  even  at  4°C  or  15°C, 
where vesicular transport  from the Golgi to the plasma 
membrane is strongly suppressed (13, 29, 40, 50, 67, 79), 
suggests that the plasma membrane is also a bona fide site 
of S-acylation of these species. 
Discussion 
The cysteinyl lipopeptides used in this study offer several 
significant potential advantages as model substrates to ex- 
amine  in  situ  the  S-acylation of cysteinyl-containing se- 
quences  (including,  though  not  necessarily  limited  to, 
those occurring in N-acylated or prenylated proteins) in 
mammalian cells. First, the uncharged lipopeptides, being 
diffusible and membrane permeant, can be incorporated 
into cells under readily controlled conditions. Second, the 
S-acylated forms of the lipopeptides can readily be sepa- 
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scopic localization  of the intra- 
cellular  site  of  S-acylation  of 
myrC-  and  myrCG-edNBD  in 
CV-1 cells. (a)  Cells incubated 
with 50 ixM myrC-edNBD for 
2 h at 37°C. (b) Cells incubated 
with 50 CM myrS-edNBD for 
4 h at 15°C (compare with cells 
similarly incubated  with  myrC- 
edNBD in  (e).  (c and d)  Cells 
coincubated  with  10  ~M 
myrCG-edNBD and 40 ~M Cs- 
DECA-ceramide for 4 h at 15°C: 
(c)  NBD  fluorescence;  (d)  C8- 
DECA-ceramide  fluorescence. 
(e and 3') as (c and d), but using 
myrC-edNBD  in  place  of 
myrCG-edNBD. Before micro- 
scopic observation  all cell sam- 
ples  except  that  in  (b)  were 
washed  with  albumin  as  de- 
scribed in Materials  and  Meth- 
ods; albumin washing of cells in- 
cubated  as  in  (b)  removed 
essentially all detectable fluores- 
cence. Bar, 10 Ixm. 
rated  chromatographically from unmodified  lipopeptide 
and quantitated by fluorescence to determine the absolute 
quantities of modified lipopeptide synthesized. Third, it is 
possible  to  employ  unnaturally  lipid-modified  lipopep- 
tides, representing potential S-acylation motifs that cannot 
be introduced into recombinant proteins (e.g., sequences 
containing terminal N-myristoylated amino acid residues 
other than glycine), to aid in mapping the specificity of the 
S-acylation process. Finally, the nondiffusible character of 
the lipopeptides in their S-acylated form (76) permits their 
selective localization in cells by fluorescence microscopy 
after removing unmodified lipopeptide with albumin. It is 
thereby possible to visualize the cellular membrane com- 
partment(s) in which the S-acylation process takes place, 
particularly when ceils are incubated with lipopeptides at 
reduced temperatures (4 or 15°C)  where S-acylation still 
occurs  but  vesicle-mediated  transport  of  materials  be- 
tween many membrane compartments is suppressed. 
Various lines of evidence lead to the conclusion that the 
S-acylation of lipopeptides like those  examined here by 
CV-1 and other mammalian cells represents an enzymatic 
activity. As already discussed in the Results section, com- 
parison of the S-acylation of cellular proteins and of exog- 
enous cysteinyl lipopeptides strongly suggests that the li- 
popeptide-acylation process does not primarily reflect the 
nonspecific abstraction of S-acyl groups from proteins by 
lipopeptides. The lipopeptide S-acylation process is equally 
unlikely to be mediated by nonenzymic transfer of S-acyl 
groups from cytoplasmic acyl donor molecules, for three 
reasons. First, cytoplasmic long chain acyl-CoAs, the most 
likely candidate donor for such a  reaction, are normally 
tightly bound to specific intracellular binding proteins (59, 
60) and in this form might not be expected to participate 
efficiently in nonspecific acyl transfer reactions. Second, 
the essentially absolute requirement of the S-acylation re- 
action for a lipophilic anchoring group on the peptide ac- 
ceptor  suggests  that  this  reaction  takes  place  within  a 
membrane  and  not  a  cytoplasmic environment.  Finally, 
the highly compartment-specific localization of the S-acy- 
lated  products  derived  from  the  cysteinyl  lipopeptides 
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tion that S-acylation occurs by nonspecific acyl transfer 
from a cytoplasmic acyl donor. 
Several points suggest that the plasma membrane-local- 
ized enzyme(s) mediating the S-acylation of the lipopep- 
tides examined here may be the same as that responsible 
for the  S-acylation of at least  some plasma membrane- 
associated proteins. First, the lipopeptide acylating activity 
shows strong specificity for cysteinyl over serinyl residues 
and  for  membrane-associating  over  purely  hydrophilic 
[lipo]peptides,  although various types of membrane an- 
chors can support S-acylation. These properties are very 
similar to those reported for the S-acylation of proteins 
such as G-protein oL subunits and lck-homologous nonre- 
ceptor tyrosine kinases in cultured mammalian cells (2, 17, 
25, 41, 52, 62, 64, 77, 78, 87, 90, 91). Second, the S-acylation 
of  the  representative  lipopeptide  myrGCG-edNBD  re- 
sembles the S-acylation of cellular proteins in its sensitiv- 
ity to inhibition by tunicamycin. Third, the finding that a 
variety of plasma membrane-associated proteins (includ- 
ing proteins bearing N-terminal myrGC- motifs) undergo 
dynamic S-acylation (16,  17, 39,  46,  51,  82,  86)  strongly 
suggest that the plasma membrane itself may be an impor- 
tant locus of S-acylation (19), in agreement with our find- 
ing that this membrane is the preferred locus of S-acyla- 
tion  of lipopeptides  bearing  similar  cysteine-containing 
motifs. Fourth, our finding that myrGCG-edNBD is S-acy- 
lated predominantly but not exclusively by palmitic acid in 
CV-1 cells is consistent with two recent reports (4,19) sug- 
gesting that palmitoyl-CoA is the preferred but not the 
exclusive acyl donor for in vitro S-acylation of certain lck- 
homologous tyrosine kinases  and heterotrimeric G-pro- 
tein tx subunits. Finally, Berthiaume and Resh (4) have re- 
cently demonstrated an activity found in the membrane 
fraction of bovine brain lysate which mediates the palmi- 
toyl-CoA-dependent  S-acylation of recombinant  myris- 
toylated  p59  ry"  and  of  chimeric  constructs  bearing  an 
N-terminal myrGC- motif. The activity was found to be in- 
hibited by myristoylated dodecapeptides bearing this motif, 
at concentrations similar to those at which the myrGC- 
based  lipopeptides  studied here  serve  as  efficient sub- 
strates for S-acylation in intact cells.  Unfortunately, the 
study just  noted  did  not  examine inhibition of protein 
S-acylation by shorter cysteinyl lipopeptides, nor did it de- 
termine whether (as our results would suggest) the myris- 
toylated dodecapeptides serve as substrates as well as in- 
hibitors for the S-acylation process. 
Our findings that lipopeptides such as myrXCZ-edNBD 
are effective substrates for S-acylation at the plasma mem- 
brane but not the Golgi apparatus, while species such as 
myrCG-edNBD are readily S-acylated in both compart- 
ments, suggest that the two compartments contain distinct 
S-acylating activities with different intrinsic substrate spe- 
cificities.  The  observation  that  lipopeptides  bearing  a 
myrGC- or -CXC(farn)-OMe motif are S-acylated (and con- 
sequently accumulated) preferentially at the plasma mem- 
brane is consistent with evidence suggesting that S-acyla- 
tion  of  proteins  bearing  such  motifs  may  target  them 
specifically to  this membrane  compartment  (25,  26,  78, 
91). As we have noted previously (76), proteins bearing a 
myrGC- or -CXC(prenyl)-OMe motif that acquire a sec- 
ond (S-acyl) hydrophobic chain while associated with a 
particular membrane are expected to become kinetically 
trapped at the surface of that membrane until the S-acyl 
group is removed. The S-acylation of such motifs preferen- 
tially at the plasma membrane thus affords a simple mech- 
anism for plasma membrane targeting (or sequestration) 
of proteins bearing these potential S-acylation sites. While 
lipopeptides such as myrC- and myrCG-edNBD represent 
obviously unphysiological S-acylation motifs, the  mem- 
brane disposition of the cysteine residue in such lipopep- 
tides (in contrast to that in the other lipopeptides exam- 
ined  here)  may  mimic  that  of  cysteine  residues  lying 
precisely at the cytoplasmic junction between transmem- 
brane  and extramembrane sequences,  as is  the case for 
various proteins  that undergo  posttranslational S-acyla- 
tion in a  Golgi (or pre-Golgi transitional) compartment 
(56,  68).  Further  study  will  be  required  to  determine 
within which subcompartment(s) of the Golgi complex the 
observed S-acylation of such lipopeptides takes place, and 
what  other  [lipo]peptide  sequences  and  anchor  groups 
may support S-acylation in this compartment. 
The use of lipopeptides varying in their sequence and in 
their lipid anchor provides interesting information on the 
selectivity of the S-acylation process  at the level of the 
plasma membrane. It is clear that the S-acylating activity 
(or activities) in this membrane can accept as substrates li- 
popeptides bearing a variety of physiological and unphysi- 
ological anchor motifs so long as these are sufficiently hy- 
drophobic  to  promote membrane association. The  very 
similar efficiencies of S-acylation observed for myristoy- 
lated and farnesylated lipopeptides with the core sequence 
-GCG- (Fig. 8 D) suggests that prenylated and N-myris- 
toylated lipopeptides may be substrates for a  common 
S-acylating  activity.  Our  results  with  myristoylated li- 
popeptides of varying sequence also indicate that the gly- 
cine residue in the physiological myrGC- S-acylation mo- 
tif, while optimal, is not essential for S-acylation. Instead, 
the efficiency of acylation appears to decrease, but is not 
abolished, as the sites flanking the modifiable cysteine are 
substituted  with  progressively  bulkier  (and  particularly 
beta-branched) amino acid residues. This finding is consistent 
with observations that certain G~ proteins can be S-acylated 
when their normal NH2-terminal myrGC- motif is replaced 
with an unmyristoylated AC- motif, and that -XC- motifs 
(where X may be a nonglycine amino acid) are S-acylated in 
wild-type G~ proteins such as et  s and Otl2/Ctl3 , if membrane 
anchorage is mediated by association of the et subunit with 
Gpx (16, 17, 35, 85, 90). 
It remains to be determined whether one or multiple en- 
zymes mediate  S-acylation of plasma  membrane-associ- 
ated proteins, which vary both in the nature of their S-acy- 
lation sites and in their mode of membrane association. It 
is logical to suggest that the cysteinyl-containing lipopep- 
tides  examined here  are  substrates  for the  S-acyltrans- 
ferase(s) that mediate(s) S-acylation of cellular proteins 
bearing similar cysteine-containing, lipid-modified termi- 
nal motifs. It is an open question whether the same S-acyl- 
transferase(s) can mediate physiological S-acylation of in- 
tegral  membrane  proteins,  either  on  cysteine  residues 
within or contiguous to transmembrane segments or on 
cysteine residues further removed from a transmembrane 
domain. Integral membrane proteins may of course present 
sites for S-acylation that differ markedly in sequence and/ 
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associating  proteins  bearing  myrGC-  or  -CXnC(prenyl)- 
OMe  motifs.  It  is  however  interesting  to  note  that  the 
plasma  membrane-associated  S-acyltransferase(s)  acting 
on lipid-modified peptides exhibit(s) relatively broad speci- 
ficity  for  both  the  cysteinyl-containing  sequence  to  be 
modified and the means by which the cysteinyl residue is 
brought  into proximity with the membrane  surface.  It is 
thus  conceivable  that  at  least  some  integral  membrane 
proteins  may  serve  as  substrates  for  the  plasma  mem- 
brane-associated  S-acyltransferase(s)  detected  here using 
lipopeptide substrates.  Lipid-modified peptides may pro- 
vide a useful tool (as substrates and, potentially, as inhibitors) 
to elucidate  further the  nature  and  possible  diversity  of 
plasma protein S-acyltransferases in future studies using in- 
tact or solubilized plasma membrane preparations. 
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